OS Therapies raises $7.53M via warrant exercise inducement from all 9 existing holders

OS Therapies Inc

Gross proceeds of $7.53M from exercise or pre-funding of 5,382,148 Existing Warrants at $1.40/share.
New Warrants issued for up to 5,382,148 shares at $1.40, exercisable immediately for 5 years.
Net proceeds to fund OST-HER2 BLA/MMA filings, commercial prep, and OS Animal Health spinoff.
BLA for OST-HER2 in metastatic osteosarcoma expected by end of January 2026 under Accelerated Approval.
Company expects cash runway into 2027; all 9 accredited investors offered agreed to participate.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

OS Therapies Inc entered into Inducement Letters with less than 10 accredited investors valued at approximately $7.5 million (effective 2026-01-10).

Action: entry
Agreement: equity purchase
Counterparty: less than 10 accredited investors
Value: approximately $7.5 million
Effective: 2026-01-10

Exact text from the filing

On January 10, 2026, OS Therapies Incorporated (the “Company”) entered into inducement offer letter agreements (the “Inducement Letters”) with less than 10 accredited investors (the “Holders”)

View on SEC.gov

294 material agreements filed in the last 30 days. Browse all material agreements →

OS Therapies Inc filing history →

Source: SEC EDGAR

accession 0001213900-26-003166

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.